Langerhan Cell Histiocytosis Treatment Options :: Nationwide Children's Hospital

Langerhan Cell Histiocytosis (LCH) Treatment Options

The Section of Hematology/Oncology offers treatment for children, adolescents and young adults with LCH. The treatment protocols are sponsored by The Histiocyte Society.

Treatment depends upon the individual patient. In most cases, the disease would likely heal by itself without treatment. Thus, the goal of any therapy is to prevent irreversible damage to normal tissue by the LCH lesions before they have a chance to spontaneously resolve. Solitary lesions may be treated with surgery alone if the lesion can be completely removed. Chemotherapy and/or small doses of radiation may be prescribed, depending on the extent of the disease.

To read about the signs and symptoms, diagnosis and treatment of LCH, click here.

Treatment Outcomes

Nationwide Children's Hospital has the largest and most advanced pediatric cancer program in Ohio – and one of the largest in the nation. In 2004, more than 1,000 children were treated at Nationwide Children's – the highest number of pediatric oncology inpatient visits in the state. More than 75 percent of children who receive a diagnosis of cancer in 2005 will be cancer-free five years later, but much work remains to be done to find cures for cancers for which there is no effective pro-tocol. Nationwide Children's Research Institute ranks in the top 10 of free-standing pediatric research centers based on National Institutes of Health funding.

Learn more about pediatric cancer research

Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000